Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Data In The Raw: Yale Doc Hopes Medtronic Infuse Effort Will Spark Data Transparency Model

This article was originally published in The Gray Sheet

Executive Summary

The Yale physician behind Medtronic’s recent decision to hand over all of its raw data on the embattled Infuse spinal bone graft for independent analyses and ultimate release to the broader research community sees the development as not only a smart decision for Medtronic but also as a major step forward in creating a model for the device and drug industries.

Related Content

TCT 2016: Researchers Argue For More Medtech Data Sharing
Researchers Debate Costs Of Clinical Trial Data Sharing At IOM Gathering
J&J Works Toward Device Data-Sharing Agreement Following Pharma Plan
No Advantage For Medtronic’s InFuse Versus Bone Graft In Spine Fusion
Medtronic Growth Plan: Boost R&D Productivity, Globalization
News In Brief
Medtronic Infuse Saga Prompts Questions About FDA Approval Process
Avandia Aftershocks: Will FDA Drug Safety Review Structures Crumble?
Regs Or No Regs, FDA Will Seek Adherence To Mandates
Regs Or No Regs, FDA Will Seek Adherence To Mandates





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts